Chronic inflammation in FMF: Markers, risk factors, outcomes and therapy

Ilan Ben-Zvi, Avi Livneh*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Familial Mediterranean fever (FMF) is the most common of the hereditary periodic fever syndromes. Although the typical clinical course of FMF is characterized by bouts of painful inflammation, this presentation represents only the tip of the iceberg. In many patients inflammation can persist in attack-free periods, as shown by high levels of acute-phase proteins, cytokines and inflammation-induced proteins. This subclinical inflammation puts patients at risk of developing complications such as anemia, splenomegaly, decreased bone mineral density, heart disease and life-threatening amyloid A amyloidosis, among others. In this article, we review the published data on markers and other factors involved in the persistence of inflammation in patients with FMF during attack-free periods, examine the risk factors for the development of this subclinical inflammation, summarize the complications of chronic inflammation in FMF and propose a new strategy for treatment, based on these data.

Original languageEnglish
Pages (from-to)105-112
Number of pages8
JournalNature reviews. Rheumatology
Issue number2
StatePublished - Feb 2011
Externally publishedYes


Dive into the research topics of 'Chronic inflammation in FMF: Markers, risk factors, outcomes and therapy'. Together they form a unique fingerprint.

Cite this